INDBInternet News Database 2.5 Updated 2 min ago · 297 sources Show or hide images Light or dark

Bulevirtide May Reduce Liver Decompensation in HDV-Cirrhosis

1 source1 article First seen Updated United States Truth score 38

Save Like Comments Compare coverage

Summary

Bulevirtide use in patients with hepatitis D-related cirrhosis is linked with less liver decompensation over 3 years, but its effect on liver cancer risk remains unclear.

Description from Medscape.

Who is covering this

  1. Medscape Center Factuality: Mostly factual US
    Bulevirtide May Reduce Liver Decompensation in HDV-Cirrhosis

    Bulevirtide use in patients with hepatitis D-related cirrhosis is linked with less liver decompensation over 3 years, but its effect on liver cancer risk remains unclear.

Comments

Comments need JavaScript.